ENOV: Enovis Corporation Stock

by  •  • Comments Off on ENOV: Enovis Corporation Stock

SIC 3842 – Orthopedic, Prosthetic, and Surgical Appliances and Supplies

Valuation
Market Cap ($M) 3,038.16
Enterprise Value ($M) 4,312.87
Book Value ($M) 3,310.84
Book Value / Share 60.37
Price / Book 0.92
NCAV ($M) -1,017.12
NCAV / Share -18.55
Price / NCAV -2.99

Profitability (mra)
Return on Invested Capital (ROIC) -0.02
Return on Assets (ROA) -0.02
Return on Equity (ROE) -0.02

Liquidity (mrq)
Quick Ratio 1.03
Current Ratio 2.10

Balance Sheet (mrq) ($M)
Current Assets 1,150.72
Assets 5,478.68
Liabilities 2,167.84
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,707.20
Operating Income -45.67
Net Income -33.26
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 134.99
Cash from Investing -242.47
Cash from Financing 127.80

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-05 13G/A BlackRock Inc. 10.50 8.41
02-14 13G/A T. Rowe Price Investment Management, Inc. 12.10 8.97
02-13 13G/A Vanguard Group Inc 8.98 7.13
02-12 13G/A Durable Capital Partners LP 0.00 -100.00
02-09 13G/A Dimensional Fund Advisors Lp 5.80 15.60

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 441,876 1,496,698 29.52
2024-05-01 98,265 567,125 17.33
2024-04-30 114,739 451,329 25.42
2024-04-29 64,391 382,943 16.81

(click for more detail)

Similar Companies
BSX – Boston Scientific Corporation CDRE – Cadre Holdings, Inc.
CNMD – CONMED Corporation EW – Edwards Lifesciences Corporation
FNA – Paragon 28, Inc.


Financial data and stock pages provided by
Fintel.io